Common over-the-counter medication slashes colorectal cancer recurrence in half
A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back.
In a Swedish study, a low dose of aspirin was shown to slash recurrence in half for patients with colon and rectal cancer whose tumors had a specific type of genetic Мутация.
откриватели в Karolinska Institutet и Karolinska University Hospital последваха повече от 3500 пациенти с рак от 33 лечебни заведения в Швеция, Норвегия, Дания и Финландия, се споделя в известие за пресата. All patients had undergone surgery to remove their tumors.
Among those who had a particular gene mutation in the PIK3 signaling pathway, half of them received 160 milligrams of aspirin daily and the other half received a placebo.
After a three-year period, the risk of cancer recurrence was reduced by 55% in those who took the aspirin compared with the placebo Група.
Често срещано лекарство без рецепта може доста да понижи риска о...
Прочетете целия текст »
